Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v1-EN
Language English English
Date Updated 2023-10-31 2023-09-19
Drug Identification Number 02242821 02242821
Brand name SANDOZ CYCLOSPORINE SANDOZ CYCLOSPORINE
Common or Proper name CYCLOSPORINE CYCLOSPORINE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CYCLOSPORINE CYCLOSPORINE
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30SGC 30SGC
ATC code L04AD L04AD
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2023-09-19 2023-09-19
Estimated end date 2023-11-03 2023-10-06
Actual end date 2023-10-30
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments